Immune cell therapy trial offers new hope for kids with tough cancer
NCT ID NCT02573896
First seen Mar 24, 2026 · Last updated Jun 14, 2026 · Updated 10 times
Summary
This early-phase trial tests a treatment that uses a child's own natural killer (NK) cells, boosted in the lab, along with standard antibody therapy (dinutuximab) for relapsed or hard-to-treat neuroblastoma. The study aims to find the safest dose of NK cells and see if adding lenalidomide is possible. It involves children up to age 30 with high-risk neuroblastoma that has come back or not responded to prior treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, 30322, United States
-
C.S Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104-4318, United States
-
Childrens Hospital Boston, Dana-Farber Cancer Institute.
Boston, Massachusetts, 02115, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Cook Children's Healthcare System
Fort Worth, Texas, 76104, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115, United States
-
University of Chicago Comer Children's Hospital
Chicago, Illinois, 60637, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.